NutriBand (NTRB) Research & Development (2021 - 2026)
NutriBand (NTRB) posted Research & Development of $322,194 for fiscal Q2 2027 (quarter ended Jul 31, 2026), down 42.7% from $562,554 a year earlier but up 30.3% from the prior quarter.
Powered by 
Analysis
NutriBand (NTRB) Research & Development (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Research & Development at NutriBand was $1.21 million, down 53.6% year-over-year; for FY2026 (ended Jan 31, 2026), it came in at $1.89 million, down 39.4% from FY2025.
- Annual Research & Development shows a four-year compound annual growth rate of 46.4% (FY2022 to FY2026).
- In prior fiscal years, NutriBand's Research & Development was $3.12 million in FY2025 (+59.1%), $1.96 million in FY2024 (+99.6%), $982,227 in FY2023 (+138.8%) and $411,383 in FY2022.
- Quarterly Research & Development has run from a low of $117,814 in fiscal Q1 2023 to a high of $974,535 in fiscal Q1 2025 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last seven quarters, with an average decline of 28.3% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q1 2024, with growth of 239.9%; the weakest was fiscal Q1 2027, with a decline of 63.8%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $247,261 (Q1 2027), $188,036 (Q4 2026) and $457,113 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | NutriBand | 100.04 Mn | 82.73 Mn | 181,874.00 | 322,194.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 322,194.00 |
| Apr 30, 2026 | 247,261.00 |
| Jan 31, 2026 | 188,036.00 |
| Oct 31, 2025 | 457,113.00 |
| Jul 31, 2025 | 562,554.00 |
| Apr 30, 2025 | 683,426.00 |
| Jan 31, 2025 | 489,856.00 |
| Oct 31, 2024 | 880,768.00 |
| Jul 31, 2024 | 773,975.00 |
| Apr 30, 2024 | 974,535.00 |
| Jan 31, 2024 | 563,370.00 |
| Oct 31, 2023 | 551,503.00 |
| Jul 31, 2023 | 445,122.00 |
| Apr 30, 2023 | 400,430.00 |
| Jan 31, 2023 | 295,826.00 |
| Oct 31, 2022 | 290,718.00 |
| Jul 31, 2022 | 277,869.00 |
| Apr 30, 2022 | 117,814.00 |
| Jan 31, 2022 | 250,383.00 |
| Oct 31, 2021 | 161,000.00 |
API Access
NutriBand Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NTRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NTRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NTRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();